Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Spital

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|May 14, 2025
Patient-Reported Social Impact of Molecularly Confirmed Retinitis PigmentosaNina Zehe-Lindau, Birgit Lindau, Heidi Stöhr, et al.
Acta Ophthalmologica|December 7, 2019
Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE studyGabriele E Lang, Andreas Stahl, Jessica Voegeler, et al.
Journal of Clinical Medicine|November 27, 2025
Patient-Reported Social Impact of Molecularly Confirmed Macular Dystrophies and Cone-Rod DystrophiesNina Zehe-Lindau, Birgit Lindau, Heidi Stöhr, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Visual prognosis of second eyes in patients with unilateral late exudative age-related macular degenerationDaniel Pauleikhoff, Martin Radermacher, Georg Spital, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2019
[Analysis of the "Portal" Care Model - Examination of the Outcome Quality of IVOM Therapy with Regard to Latency Periods in Exudative AMD]Kai Rothaus, Marie-Louise Farecki, Peter Mussinghoff, et al.
Acta Ophthalmologica|June 14, 2021
Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE studyGabriele E Lang, Andreas Stahl, Jessica Voegeler, et al.
International Ophthalmology|January 14, 2022
Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degenerationHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Retina (Philadelphia, Pa.)|December 15, 2015
RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term PrognosisBritta Heimes, Marie-Louise Farecki, Sina Bartels, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 25, 2017
Characteristics of type 1 and 2 CNV in exudative AMD in OCT-AngiographyMarie-Louise Farecki, Matthias Gutfleisch, Henrik Faatz, et al.
Acta Ophthalmologica|November 2, 2017
The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedemaGabriele E Lang, Sandra Liakopoulos, Jessica Vögeler, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|May 14, 2025
Patient-Reported Social Impact of Molecularly Confirmed Retinitis PigmentosaNina Zehe-Lindau, Birgit Lindau, Heidi Stöhr, et al.
Acta Ophthalmologica|December 7, 2019
Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE studyGabriele E Lang, Andreas Stahl, Jessica Voegeler, et al.
Journal of Clinical Medicine|November 27, 2025
Patient-Reported Social Impact of Molecularly Confirmed Macular Dystrophies and Cone-Rod DystrophiesNina Zehe-Lindau, Birgit Lindau, Heidi Stöhr, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Visual prognosis of second eyes in patients with unilateral late exudative age-related macular degenerationDaniel Pauleikhoff, Martin Radermacher, Georg Spital, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2019
[Analysis of the "Portal" Care Model - Examination of the Outcome Quality of IVOM Therapy with Regard to Latency Periods in Exudative AMD]Kai Rothaus, Marie-Louise Farecki, Peter Mussinghoff, et al.
Acta Ophthalmologica|June 14, 2021
Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE studyGabriele E Lang, Andreas Stahl, Jessica Voegeler, et al.
International Ophthalmology|January 14, 2022
Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degenerationHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Retina (Philadelphia, Pa.)|December 15, 2015
RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term PrognosisBritta Heimes, Marie-Louise Farecki, Sina Bartels, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 25, 2017
Characteristics of type 1 and 2 CNV in exudative AMD in OCT-AngiographyMarie-Louise Farecki, Matthias Gutfleisch, Henrik Faatz, et al.
Acta Ophthalmologica|November 2, 2017
The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedemaGabriele E Lang, Sandra Liakopoulos, Jessica Vögeler, et al.
Pageof 6